Parkwalk Advisors logo

Parkwalk Advisors

Europe, England, United Kingdom, London

Description

Parkwalk Advisors is a leading UK-based investment management firm with a distinct focus on technology companies emerging from the United Kingdom's world-class universities and research institutions. Recognized as one of the largest and most active investors in this specialized deep tech ecosystem, Parkwalk leverages the intellectual property and research excellence of institutions such as Oxford, Cambridge, Imperial College London, and University College London. Their core strategy revolves around identifying and nurturing early-stage ventures that possess significant commercial potential derived directly from academic breakthroughs and scientific innovation.

Parkwalk manages substantial capital, with assets under management exceeding £400 million, which translates to approximately $500 million USD. This capital is strategically deployed across a diverse portfolio that includes over 150 companies, underscoring their commitment to fostering a broad spectrum of emerging technologies. Their investment thesis spans critical sectors such as artificial intelligence, quantum computing, advanced materials, life sciences, and clean technology, all originating from cutting-edge university research. They typically engage in early-stage funding rounds, often serving as the initial institutional investor, providing crucial seed and Series A capital.

Initial investment sizes from Parkwalk Advisors typically range from £500,000 to £5 million, which corresponds to approximately $630,000 to $6.3 million USD. They are also prepared to make significant follow-on investments as their portfolio companies achieve key milestones and demonstrate growth, showcasing a long-term commitment to their ventures. Beyond capital, Parkwalk offers invaluable strategic guidance and access to an extensive network of industry experts, assisting academic founders in navigating the complexities of commercialization. Their expertise in structuring investments under the UK's Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) is a key differentiator, attracting both sophisticated investors and promising university spin-outs.

Investor Profile

Parkwalk Advisors has backed more than 324 startups, with 10 new investments in the last 12 months alone. The firm has led 87 rounds, about 27% of its total and boasts 30 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States.
  • Strong thematic focus on Biotechnology, Software, Health Care.
  • Led 4 rounds in the past year.
  • Typical check size: $630K – $6.3M.

Stage Focus

  • Seed (28%)
  • Series A (28%)
  • Series Unknown (16%)
  • Series B (15%)
  • Series C (6%)
  • Post Ipo Equity (3%)
  • Pre Seed (1%)

Country Focus

  • United Kingdom (97%)
  • United States (3%)

Industry Focus

  • Biotechnology
  • Software
  • Health Care
  • Manufacturing
  • Information Technology
  • Medical
  • Artificial Intelligence (Ai)
  • Medical Device
  • Energy
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Parkwalk Advisors frequently co-invest with?

Martlet Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 14
Business Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 13
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 16
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 13
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 11
Amadeus Capital Partners
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 18
IP Group
Europe, England, United Kingdom, London
Co-Investments: 37
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 41
IQ Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 14
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 22

Which angels does Parkwalk Advisors often collaborate with?

MG
Europe, England, United Kingdom, London
Shared Deals: 1
David Evans
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
Shared Deals: 1
PF
North America, Massachusetts, United States, Cambridge
Shared Deals: 3
Paul Mears
Asia, Hong Kong Island, Hong Kong, Hong Kong
Shared Deals: 1
AM
Europe, England, United Kingdom, London
Shared Deals: 2
MG
North America, California, United States, San Francisco
Shared Deals: 1
PW
Europe, England, United Kingdom, London
Shared Deals: 1
PC
Europe, England, United Kingdom, London
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 12

What are some of recent deals done by Parkwalk Advisors?

Bitfount

London, England, United Kingdom

Federated data science and AI platform for privacy-preserving analytics & AI/ML

AnalyticsArtificial Intelligence (AI)Big DataCollaborationInformation ServicesInformation TechnologyMachine LearningSoftware
Series AJul 23, 2025
Amount Raised: $8,000,000
Ceryx Medical

Bath, Bath and North East Somerset, United Kingdom

Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology.

Health CareMedical Device
Series UnknownJun 11, 2025
Amount Raised: $6,736,465
Brainomix

Oxford, Oxfordshire, United Kingdom

Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions

Artificial Intelligence (AI)BiotechnologyMachine LearningMedicalMedical DevicePrecision MedicineSoftware
Series CMar 18, 2025
Amount Raised: $18,163,655
Cambridge GaN Devices

Cambridge, Cambridgeshire, United Kingdom

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

ElectronicsManufacturingSemiconductor
Series CFeb 18, 2025
Amount Raised: $32,000,000
illumion

Cambridge, Cambridgeshire, United Kingdom

Illumion uses light to alter energy storage.

ManufacturingRenewable Energy
SeedDec 4, 2024
Amount Raised: $2,667,158
PervasID

Cambridge, Cambridgeshire, United Kingdom

PervasID is developing a high reliability

Developer ToolsEnterprise SoftwareService Industry
Series UnknownNov 21, 2024
Amount Raised: $4,090,113
Diffblue

Oxford, Oxfordshire, United Kingdom

Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests.

Artificial Intelligence (AI)Developer ToolsGenerative AISoftware
Series AOct 30, 2024
Amount Raised: $6,300,000
Ikarovec

Cambridge, Cambridgeshire, United Kingdom

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

BiotechnologyHealth CareLife Science
SeedOct 23, 2024
Amount Raised: $10,333,234
Evoralis

Cambridge, Cambridgeshire, United Kingdom

Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes.

BiotechnologyRecycling
SeedSep 17, 2024
Amount Raised: $3,291,813
PhoreMost

Cambridge, Cambridgeshire, United Kingdom

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

BiopharmaBiotechnologyHealth Care
Series BSep 12, 2024
Amount Raised: $12,000,000